Pyxis Oncology, Inc.
PYXS
$1.34
$0.021.52%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 88.94M | 105.43M | 126.93M | 144.82M | 155.72M |
Total Receivables | 3.00M | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 6.54M | 4.97M | 761.00K | 2.58M | 3.84M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1.47M | 1.47M | 4.75M | 1.47M | 1.47M |
Total Current Assets | 99.96M | 111.87M | 132.44M | 148.87M | 161.04M |
|
|||||
Total Current Assets | 99.96M | 111.87M | 132.44M | 148.87M | 161.04M |
Net Property, Plant & Equipment | 20.77M | 21.45M | 22.14M | 22.82M | 23.68M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 2.49M | 2.54M | 2.60M | 23.62M | 23.68M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 123.22M | 135.87M | 157.18M | 195.31M | 208.39M |
|
|||||
Total Accounts Payable | 9.41M | 2.85M | 4.86M | 4.87M | 5.47M |
Total Accrued Expenses | 6.70M | 10.08M | 10.73M | 14.06M | 10.09M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.57M | 1.51M | 1.45M | 1.39M | 1.34M |
Total Finance Division Other Current Liabilities | -- | -- | 643.00K | -- | -- |
Total Other Current Liabilities | -- | -- | 643.00K | -- | -- |
Total Current Liabilities | 17.68M | 14.43M | 17.68M | 20.32M | 16.90M |
|
|||||
Total Current Liabilities | 17.68M | 14.43M | 17.68M | 20.32M | 16.90M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 17.89M | 18.33M | 18.75M | 19.15M | 19.53M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | 2.16M | 2.16M |
Total Liabilities | 35.57M | 32.76M | 36.43M | 41.63M | 38.60M |
|
|||||
Common Stock & APIC | 490.72M | 487.77M | 484.14M | 481.31M | 476.68M |
Retained Earnings | -403.07M | -384.71M | -363.56M | -327.99M | -306.78M |
Treasury Stock & Other | -5.00K | 49.00K | 170.00K | 351.00K | -102.00K |
Total Common Equity | 87.64M | 103.10M | 120.75M | 153.68M | 169.79M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 87.64M | 103.10M | 120.75M | 153.68M | 169.79M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 87.64M | 103.10M | 120.75M | 153.68M | 169.79M |
|